TK2d Patient Voices Elevated at FDA; United Mitochondrial Disease...

In a historic first, the Food and Drug Administration (FDA) held a listening session regarding Thymidine kinase 2 deficiency (TK2d), a rare mitochondrial disease and enzyme deficiency. The Jan. 31,...(PRWeb February 04, 2022)Read the full story at https://www.prweb.com/releases/2022/02/prweb18473220.htm
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Source Type: news